Form 4: CVS Health Director Michael Mahoney Reports Acquisition of Common Stock and Deferred Stock Units
SEC Form 4 Filing
Director Michael Mahoney reports acquisition of CVS Health common stock and deferred stock units related to director compensation.
Summary
- Michael F. Mahoney, a director of CVS Health Corp, reported a transaction on May 15, 2025.
- Mahoney acquired 144 shares of common stock at a price of $60.47 per share as payment for a semi-annual retainer.
- He also acquired 2,542.5831 deferred stock units related to deferral of a semi-annual retainer, also valued at $60.47 per unit.
- Following the reported transactions, Mahoney beneficially owns 6,345 shares of common stock directly and 2,542.5831 deferred stock units.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing simply reports routine director compensation transactions.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for directors of publicly traded companies. It provides transparency into the compensation and stock ownership of company insiders.
Comparison to Industry Standards
- Director compensation packages, including stock and deferred stock units, are standard practice among publicly traded companies like CVS Health.
- Companies such as Walgreens Boots Alliance (WBA) and UnitedHealth Group (UNH) also utilize similar compensation structures for their board members.
Related Party Transactions
- The acquisition of common stock and deferred stock units is a related party transaction as it involves compensation to a director of the company.
Stakeholder Impact
- The transaction has minimal direct impact on stakeholders, as it is a routine part of director compensation.
- It provides transparency to shareholders regarding director compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Date of transaction: acquisition of common stock and deferred stock units. |
| 05/19/2025 | Date of signature on the Form 4 filing. |
Keywords
CVS Health, Director, Michael Mahoney, Form 4, Common Stock, Deferred Stock Units, Insider Trading, Compensation, Retainer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.